CliffBio
small molecule

TRIAMTERENE AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; TRIAMTERENE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active ingredientHYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength50MG;75MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 1988
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.